Raising diagnoses or doubts? RAISE score for transthyretin cardiac amyloidosis identification in aortic stenosis

Valvular heart disease in patients with cardiac amyloidosis

10.1007/s10741-023-10350-1 · 2024

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

10.1093/eurheartj/ehx350 · 2017

Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation

10.1093/eurheartj/ehaa170 · 2020

Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

10.1093/eurheartj/ehaf362 · 2025

Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis

10.1016/j.jacc.2020.11.006 · 2021

Cardiac transthyretin amyloidosis in aortic valve replacement: RAISE score performance in the postoperative setting

10.1007/s00392-025-02766-6 · 2026

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study

2026

External validation of the RAISE score for the diagnosis of transthyretin cardiac amyloidosis in patients with severe aortic stenosis. AMYLOCOR registry

10.1016/j.ijcard.2026.134787 · 2026